Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6104 followers
Created: 2025-07-24 06:50:56 UTC

Syngene Q1 FY26: Strong Revenue Growth & Sustainability Wins 🌱📊 | MCap XXXXXXXXX Cr

- Revenue: ₹875 Cr in Q1 FY26 (11% YoY growth)
- Operating EBITDA margin: XXXX%
- PAT before exceptional items: ₹87 Cr (59% YoY increase)
- Net cash position: ₹10,528 Mn (as of June 30, 2025)
- Market cap: ₹2,57,438 Mn (47% free float)
- Workforce: XXXXX employees (5,641 scientists)
- Clients: 400+ active, including XX of top XX pharma firms
- Patents: 400+ held with clients
- ESG: XX% renewable energy use, CO2 & water reductions
- Achievements: USFDA GCP inspection success, new peptide lab, TIME’s Most Sustainable Companies list

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of XX pages)

![](https://pbs.twimg.com/media/GwmpWTybMAA8mAU.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948274682744189417/c:line.svg)

**Related Topics**
[market cap](/topic/market-cap)
[sustainability](/topic/sustainability)
[quarterly earnings](/topic/quarterly-earnings)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1948274682744189417)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Investor_Feed Avatar Investor Feed @Investor_Feed on x 6104 followers Created: 2025-07-24 06:50:56 UTC

Syngene Q1 FY26: Strong Revenue Growth & Sustainability Wins 🌱📊 | MCap XXXXXXXXX Cr

  • Revenue: ₹875 Cr in Q1 FY26 (11% YoY growth)
  • Operating EBITDA margin: XXXX%
  • PAT before exceptional items: ₹87 Cr (59% YoY increase)
  • Net cash position: ₹10,528 Mn (as of June 30, 2025)
  • Market cap: ₹2,57,438 Mn (47% free float)
  • Workforce: XXXXX employees (5,641 scientists)
  • Clients: 400+ active, including XX of top XX pharma firms
  • Patents: 400+ held with clients
  • ESG: XX% renewable energy use, CO2 & water reductions
  • Achievements: USFDA GCP inspection success, new peptide lab, TIME’s Most Sustainable Companies list

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of XX pages)

XXX engagements

Engagements Line Chart

Related Topics market cap sustainability quarterly earnings investment

Post Link

post/tweet::1948274682744189417
/post/tweet::1948274682744189417